We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Second Field Evaluation of Bivalent Types 4 and 7 Adenovirus Vaccine

Maurice R. Hilleman; Capt. Jerome H. Greenberg; Mildred S. Warfield; Sally A. Anderson; Richard R. Glabere
AMA Arch Intern Med. 1958;102(3):428-436. doi:10.1001/archinte.1958.00030010428013.
Text Size: A A A
Published online


Earlier reports1-5 from this laboratory described the development and evaluation in the field of a formalin-killed bivalent adenovirus6-8 vaccine of monkey-kidney origin. The vaccine was prepared at the Walter Reed Army Institute of Research, and the evaluation consisted of a controlled field study conducted during the winter of 1956 in 624 newly inducted recruits at Fort Dix, N. J. The vaccine was highly effective, commencing one week after vaccination, and produced a 98% reduction in amount of adenovirus-caused respiratory illness. During the winter of 1957, a second controlled field evaluation of the vaccine was carried out among 8238 recruits stationed at Fort Leonard Wood, Mo. The vaccine employed in this trial was provided by Lederle Laboratories and was prepared under commercial conditions. This paper presents the findings in the field trial at Fort Leonard Wood, compares the potency values of the Lederle and Walter Reed vaccines, and presents data concerning


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

20 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.